CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −62 | $563.24 | $35K | 40,513 |
| 2026-07-07 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 49,218 | ||
| 2026-07-06 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $135.42 | $1.3M | 50,013 |
| 2026-07-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,098 | $546.93 | $1.1M | 47,915 |
| 2026-07-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,031 | $548.00 | $565K | 46,884 |
| 2026-07-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,354 | $549.03 | $1.8M | 43,530 |
| 2026-07-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,116 | $549.87 | $1.2M | 41,414 |
| 2026-07-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −329 | $550.78 | $181K | 41,085 |
| 2026-07-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −131 | $551.88 | $72K | 40,954 |
| 2026-07-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −135 | $553.39 | $75K | 40,819 |
| 2026-07-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −306 | $553.90 | $169K | 40,513 |
| 2026-07-06 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 58,718 | ||
| 2026-07-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 53,472 |
| 2026-07-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −658 | $548.00 | $361K | 52,814 |
| 2026-07-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −258 | $548.73 | $142K | 52,556 |
| 2026-07-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −384 | $550.02 | $211K | 52,172 |
| 2026-07-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,467 | $551.30 | $809K | 50,705 |
| 2026-07-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,818 | $552.61 | $1.0M | 48,887 |
| 2026-07-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,201 | $553.52 | $1.2M | 46,686 |
| 2026-07-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −299 | $554.45 | $166K | 46,387 |
Page 72 of 120 · 2,391 trades